Literature DB >> 22591405

Is vitamin D beneficial to Alzheimer disease? A surprising dilemma.

De-Li Qiao, She-Qing Zhang, Brian Giunta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22591405      PMCID： PMC6493627          DOI： 10.1111/j.1755-5949.2012.00335.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  10 in total

Review 1.  Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.

Authors:  Bruce A Yankner; Tao Lu
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

Authors:  Kavon Rezai-Zadeh; Doug Shytle; Nan Sun; Takashi Mori; Huayan Hou; Deborah Jeanniton; Jared Ehrhart; Kirk Townsend; Jin Zeng; David Morgan; John Hardy; Terrence Town; Jun Tan
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

Review 3.  Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?

Authors:  Alessandro Martorana; Zaira Esposito; Giacomo Koch
Journal:  CNS Neurosci Ther       Date:  2010-04-16       Impact factor: 5.243

Review 4.  REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state.

Authors:  Francesco Panza; Vincenza Frisardi; Bruno P Imbimbo; Cristiano Capurso; Giancarlo Logroscino; Daniele Sancarlo; Davide Seripa; Gianluigi Vendemiale; Alberto Pilotto; Vincenzo Solfrizzi
Journal:  CNS Neurosci Ther       Date:  2010-06-16       Impact factor: 5.243

5.  Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3).

Authors:  D Baas; K Prüfer; M E Ittel; S Kuchler-Bopp; G Labourdette; L L Sarliève; P Brachet
Journal:  Glia       Date:  2000-07       Impact factor: 7.452

Review 6.  Dimebolin in dementia.

Authors:  Deepak Sachdeva; Alistair Burns
Journal:  CNS Neurosci Ther       Date:  2010-06-11       Impact factor: 5.243

Review 7.  TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.

Authors:  Filippo Caraci; Giuseppe Battaglia; Valeria Bruno; Paolo Bosco; Viviana Carbonaro; Maria Laura Giuffrida; Filippo Drago; Maria Angela Sortino; Ferdinando Nicoletti; Agata Copani
Journal:  CNS Neurosci Ther       Date:  2009-11-19       Impact factor: 5.243

Review 8.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13

9.  CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.

Authors:  Yuyan Zhu; Huayan Hou; William V Nikolic; Jared Ehrhart; Elona Rrapo; Paula Bickford; Brian Giunta; Jun Tan
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322
  10 in total
  2 in total

1.  Making sense of vitamin D concentrations.

Authors:  Florin M Musteata
Journal:  Future Sci OA       Date:  2016-01-13

2.  Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Authors:  Véréna Landel; Pascal Millet; Kévin Baranger; Béatrice Loriod; François Féron
Journal:  Mol Neurodegener       Date:  2016-03-01       Impact factor: 14.195
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.